Evidence Shows Alzheimer Benefits From Genuv Cancer Drug
Mekinist (trametinib), which has been licenced by the FDA for the treatment of melanoma, was shown in a preclinical trial to have a neuroprotective...
HIV And COVID-19 Vaccines Could Benefit From Nasal Release
A team led by an assistant professor from the University of Minnesota in the US has created a new method to successfully administer vaccines through...
Three Viruses That Pharma Sector Needs To Gear Up Against
More than half of the known infectious diseases are getting worse due to climate change. Monkeypox is expanding, and recently, news of an outbreak...
Pharmacopoeias To Promote Vaccine Development And Supply
The mRNAVAC Working Party was established by the European Pharmacopoeia Commission to start developing standards of quality to support the developing area of messenger...
Why Children Are Better Protected Against COVID-19 & More
There were a lot of mysteries surrounding COVID-19, some of which have been answered, but many more have not. Since the start of the...
Korean Company GenKOre Offering Genetic Base-Editing Tech
Adenine base editors were successfully created by GenKOre, a biotech startup in South Korea, using its unique hypercompact gene-editing method.
The hypercompact ABEs created by...
GSK To Aid 12 European Countries Prepare For Future Pandemic
People and the industry have learned a lot about pandemic management by living through COVID-19. Governments all throughout the world are placing a greater...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...